United States Securities and Exchange Commission · EDGAR Accession 0001872856-26-000003

Form C/A

Offering Statement Amendment — Regulation Crowdfunding
Campaign file 020-36401
Issuer CIK 2053710
Raising via DEALMAKER SECURITIES LLC

RAM Pharmaceuticals Inc.

CorporationMSIncorporated 2024LUMBERTON, MSrampharmaceuticals.com
Nature of amendmentThis material amendment is filed to change the closing date from January 16th to April 30, 2026, and the change of employees to 1.
A

The Offering

as disclosed in this filing
Other (Series B Common Stock)
$1.00
$10,200
$1,235,000
April 30, 2026
Expired 47 days ago
$0max $1,235,000

Target is 1% of the maximum. Over-subscriptions accepted.

B

Financial Condition

two fiscal years, as filed
Pre-revenueDebt / assets 220%1 employee
Line itemMost recent FYPrior FYΔ
Revenue00
Cost of goods sold00
Net income(33,481)0
Total assets27,8570
Cash & equivalents23,4380
Accounts receivable7,4450
Short-term debt61,3380
Long-term debt00
Taxes paid00

Figures in USD as reported by the issuer. Securities offered in all 50 states.

C

Campaign Timeline

file 020-36401 · all filings under this campaign
Loading campaign history…